Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bonella

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
BMJ Open Respiratory Research|June 9, 2026
Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD)Niels Schröder, Jitka Andrä, Diana Knuth-Rehr, et al.
ERJ Open Research|January 27, 2022
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?Marlies S Wijsenbeek, Francesco Bonella, Leticia Orsatti, et al.
Advances in Therapy|May 16, 2022
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung DiseasesFrancesco Bonella, Vincent Cottin, Claudia Valenzuela, et al.
Respirology (Carlton, Vic.)|January 13, 2015
MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosisYasushi Horimasu, Shinichiro Ohshimo, Francesco Bonella, et al.
Respiratory Medicine|May 22, 2025
Recurrent pulmonary alveolar proteinosis after lung transplantation: a case seriesDirk Westhölter, Marcel Opitz, Josefine Rawitzer, et al.
Thorax|October 7, 2016
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosisMichael Kreuter, Francesco Bonella, Toby M Maher, et al.
BMC Medical Genetics|January 10, 2014
Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphismsYasushi Horimasu, Noboru Hattori, Nobuhisa Ishikawa, et al.
Advances in Therapy|February 16, 2026
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc AnalysisWim A Wuyts, Francesco Bonella, Maurizio Scarpa, et al.
Respiratory Research|April 27, 2021
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbiditiesIan Glaspole, Francesco Bonella, Elena Bargagli, et al.
BMC Pulmonary Medicine|September 17, 2017
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countriesToby M Maher, Maria Molina-Molina, Anne-Marie Russell, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
BMJ Open Respiratory Research|June 9, 2026
Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD)Niels Schröder, Jitka Andrä, Diana Knuth-Rehr, et al.
ERJ Open Research|January 27, 2022
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?Marlies S Wijsenbeek, Francesco Bonella, Leticia Orsatti, et al.
Advances in Therapy|May 16, 2022
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung DiseasesFrancesco Bonella, Vincent Cottin, Claudia Valenzuela, et al.
Respirology (Carlton, Vic.)|January 13, 2015
MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosisYasushi Horimasu, Shinichiro Ohshimo, Francesco Bonella, et al.
Respiratory Medicine|May 22, 2025
Recurrent pulmonary alveolar proteinosis after lung transplantation: a case seriesDirk Westhölter, Marcel Opitz, Josefine Rawitzer, et al.
Thorax|October 7, 2016
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosisMichael Kreuter, Francesco Bonella, Toby M Maher, et al.
BMC Medical Genetics|January 10, 2014
Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphismsYasushi Horimasu, Noboru Hattori, Nobuhisa Ishikawa, et al.
Advances in Therapy|February 16, 2026
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc AnalysisWim A Wuyts, Francesco Bonella, Maurizio Scarpa, et al.
Respiratory Research|April 27, 2021
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbiditiesIan Glaspole, Francesco Bonella, Elena Bargagli, et al.
BMC Pulmonary Medicine|September 17, 2017
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countriesToby M Maher, Maria Molina-Molina, Anne-Marie Russell, et al.
Pageof 20